Happiest Minds Technologies Ltd

- Happiest Minds has made strategic acquisitions, including the recent acquisition of the Middle East business of GAVS Technologies Limited, consolidating customer relationships and local delivery capabilities primarily in BFSI and IMSS verticals. - Investments into the Generative AI Business Services unit continue, with GenAI-related investments rising from about US $1.5 million in the first six months to about US $3.5 million up to nine months, indicating a strategic focus on growth in AI technologies. - The company is investing in the new sales engine and verticalization strategy, including hiring industry managers and establishing specialized sales teams, particularly for the BFSI vertical. - Plans include expanding operations and investments in the Middle East region. - Focus on increasing utilization rates (from 76-77% to 78-80%) as an operational lever impacting margins and overall capital efficiency.

- Expect solid organic growth, especially from the Generative AI Business Services (GBS) and verticalization initiatives. - Targeting double-digit organic growth next year, with a long-term aim to grow at 1 to 1.5 times the market rate. - Q4 expected to show steep acceleration, aiming to reach near 30% revenue growth in constant currency. - Growth driven by new sales engine, verticalization, acquisitions, and consolidation (e.g., GAVS Middle East business). - Generative AI initiatives progressing from proofs-of-concept to significant orders, contributing to future revenue. - Strong pipeline development in BFSI, healthcare, retail, and industrial sectors, with new logos and expanded existing accounts. - Anticipate revenue growth despite efficiency improvements that might lower per-order revenue but increase volume and overall revenue. - Expansion into new geographies (Middle East, Canada, Europe) supports growth prospects.

- Expectation of very solid organic growth next year, particularly from the Generative AI Business Services (GBS) and new sales initiatives. - Targeting at least 1 to 1.5x market growth as a long-term goal. - Aim to move into double-digit organic growth next year. - Q4 expected to see steep acceleration with growth around 27%-30% in constant currency. - Margin outlook: aiming to continue improving EBITDA margins beyond current 22.1%, with consolidation benefits from recent acquisitions contributing positively. - Operating margins expected to improve alongside revenues, supported by efficiencies from platforms like Arttha banking. - Cash EPS showed good year-over-year growth (12.6% last quarter), with annualized Cash EPS at ₹24.6. - Sustained commitment to investments in GenAI and new sales engines, balanced with margin expansion efforts.

- Happiest Minds does not share a specific number for the Net New (NN) order pipeline but states it is among the best they've had recently. - The company has experienced strong deal momentum, with multiple proofs of concept (POCs) underway in generative AI, about 80% expected to convert into orders. - Several prospects are in advanced stages, especially in BFSI and North American markets, with new sales leadership in Canada and planned expansion into Europe. - Recent acquisitions (PureSoftware, Aureus, and GAVS Middle East business) have added depth to the pipeline and customer base, especially in BFSI vertical. - Agreements with two Indian public sector banks to provide Arttha banking platform services contribute to pipeline strength. - Growth is expected both organically and through consolidation, with pipeline momentum anticipated to continue into FY26.

The document does not mention any current or future plans for fundraising through debt or equity for Happiest Minds Technologies Limited. Key financial highlights and strategic initiatives such as acquisitions, organic growth, margin improvements, and investments in generative AI and verticalization are discussed, but there is no reference to raising funds via debt or equity. - No indication of current or planned equity fundraise. - No mention of debt issuance or borrowing plans. - Focus remains on growth through organic means and strategic acquisitions. - Investments are internally funded, including approximately US $3.5 million in generative AI over nine months. - Strong cash and cash equivalents (₹1,495 crores) and healthy cash flow conversion (97.5% of EBITDA) suggest internal funding capability. Hence, no explicit plans for new fundraising through debt or equity are disclosed.